Literature DB >> 10074909

Molecular expression of PSMA mRNA and protein in primary renal tumors.

F Dumas1, J L Gala, P Berteau, F Brasseur, P Eschwège, V Paradis, B Lacour, M Philippe, S Loric.   

Abstract

Human prostate-specific membrane antigen (PSMA), a 100-kDa integral transmembrane glycoprotein, is considered to be a highly specific marker of the prostate gland, and has successfully been used as a marker of circulating prostatic epithelial cells. Extended PSMA homology has been demonstrated with a cDNA found in rat cerebral and renal tissues. In this study, we aimed to evaluate the expression of PSMA mRNA in a variety of human renal cancer tissues (n = 20) and cell lines (n = 12). Using reverse transcriptase-polymerase chain reaction, DNA sequencing, blottings, and specific anti-PSMA labelling with CYT 351 antibody, we identified PSMA mRNA and protein in normal and in neoplastic renal tissue. The sequence of the polymerase-chain-reaction products is identical to that of PSMA cDNA derived from prostate tissue. Immunological staining with the CYT 351 reveals that PSMA is expressed mainly in tubular cells. Since PSMA does not appear to be restricted to prostatic tissue, this novel biomarker may prove useful in the staging of renal cancer and in the search for the hematogenous spread of renal cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074909     DOI: 10.1002/(sici)1097-0215(19990315)80:6<799::aid-ijc1>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.

Authors:  Chao Zeng; Zun-Fu Ke; Zheng Yang; Zhuo Wang; Shi-Cong Yang; Can-Qiao Luo; Lian-Tang Wang
Journal:  Med Oncol       Date:  2011-10-19       Impact factor: 3.064

2.  Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer.

Authors:  Shahrokh F Shariat; Kevin M Slawin
Journal:  Rev Urol       Date:  2003

3.  Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.

Authors:  Can Cui; Masayuki Hanyu; Akiko Hatori; Yiding Zhang; Lin Xie; Tomoya Ohya; Masami Fukada; Hisashi Suzuki; Kotaro Nagatsu; Cuiping Jiang; Rui Luo; Guoqiang Shao; Mingrong Zhang; Feng Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-04-15

Review 4.  A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).

Authors:  Thomas Ahn; Matthew J Roberts; Aous Abduljabar; Andre Joshi; Marlon Perera; Handoo Rhee; Simon Wood; Ian Vela
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.

Authors:  I G McIntyre; K Spreckley; R B Clarke; E Anderson; N W Clarke; N J George
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

6.  Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.

Authors:  Timothy Kottke; Fiona Errington; Jose Pulido; Feorillo Galivo; Jill Thompson; Phonphimon Wongthida; Rosa Maria Diaz; Heung Chong; Elizabeth Ilett; John Chester; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Med       Date:  2011-06-19       Impact factor: 53.440

7.  The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.

Authors:  Sung Han Kim; Weon Seo Park; Eun Young Park; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Kang Hyun Lee; Jinsoo Chung
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

8.  Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.

Authors:  Prashant D Tailor; Sai Karthik Kodeboyina; Shan Bai; Nikhil Patel; Shruti Sharma; Akshay Ratnani; John A Copland; Jin-Xiong She; Ashok Sharma
Journal:  Oncotarget       Date:  2018-04-03

9.  Expression of prostate-specific membrane antigen in normal and malignant human tissues.

Authors:  Yoshihisa Kinoshita; Katsuyuki Kuratsukuri; Steve Landas; Katsumi Imaida; Peter M Rovito; Ching Y Wang; Gabriel P Haas
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

10.  A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.

Authors:  Hailong Zhang; Xiaogang Liu; Fengbo Wu; Feifei Qin; Ping Feng; Ting Xu; Xiang Li; Li Yang
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.